Table 6.
Clinical feature | Survived (n=36) |
Died (n=18) |
P-value |
---|---|---|---|
Shock state | 20 (55.6) | 18 (100) | 0.001 |
Cardiogenic shock | 16 (44.4) | 15 (83.3) | |
Septic shock | 2 (5.6) | 1 (5.6) | 0.009 |
Mixed shock | 2 (5.6) | 2 (11.1) | |
Use of dopamine | 11 (30.6) | 8 (44.4) | 0.239 |
Use of norepinephrine | 20 (55.6) | 17 (94.4) | 0.003 |
Use of vasopressin | 12 (33.3) | 15 (83.3) | 0.001 |
Use of adrenaline | 3 (8.3) | 6 (33.3) | 0.029 |
Use of levosimendan | 20 (55.6) | 13 (72.2) | 0.188 |
Use of phenylephrine | 4 (11.1) | 7 (38.9) | 0.023 |
Use of dobutamine | 4 (11.1) | 0 | 0.186 |
Use of intra-aortic balloon pump | 1 (2.8) | 9 (50) | 0.001 |
Mechanical ventilation | 13 (36.1) | 15 (88.2) | 0.001 |
Dialysis | 4 (11.8) | 5 (27.8) | 0.143 |
Note: Data are expressed as n (%).